Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods turns milk into gut-healthy kefir, but its SEC disclosures are where you’ll spot the numbers behind every probiotic bottle. Investors often ask where to locate milk-price sensitivity, how much revenue the ProBugs kids line contributes, or whether new distribution in the UAE affects margins. Those answers sit inside dense 10-Ks and 10-Qs—documents that can stretch past 300 pages.
Stock Titan’s AI trims the reading list. Open the Lifeway Foods quarterly earnings report 10-Q filing and our algorithm highlights same-store sales growth, inventory levels, and commodity cost hedges. Need Lifeway Foods insider trading Form 4 transactions? Real-time alerts surface every executive stock move, giving you the complete Lifeway Foods Form 4 insider transactions real-time feed without sorting through EDGAR. You’ll also find plain-language cards that make Lifeway Foods SEC filings explained simply, from Lifeway Foods annual report 10-K simplified to Lifeway Foods 8-K material events explained.
Why dig this deep? Filings reveal how Lifeway manages dairy supply contracts, tracks live-culture quality controls, and prices its expanding international lineup. In the proxy you’ll see Lifeway Foods proxy statement executive compensation that links bonuses to sales of kefir and cheese, while our dashboard delivers Lifeway Foods earnings report filing analysis that compares gut-health SKUs quarter over quarter. For advanced monitoring, set watchlists to flag Lifeway Foods executive stock transactions Form 4 before product launches. From milk procurement footnotes to distribution-channel breakdowns, our AI turns regulatory text into actionable context so you can focus on the trends—not the paperwork.
Ludmila Smolyansky, trustee and related-party to Lifeway Foods (LWAY), reported share sales totaling
The filings state the sales were multiple transactions at prices ranging between
Divisadero-related investors report collective ownership of 861,369 shares of Lifeway Foods common stock, representing
Lifeway Foods, Inc. (LWAY) notice reports a proposed sale of 15,000 common shares through RBC Capital Markets with an aggregate market value of
Juan Carlos Dalto, a director of Lifeway Foods, Inc. (LWAY), reported changes in his holdings tied to director compensation and previously granted awards. The filing shows a disposition of 4,751 shares of common stock and the acquisition (by vesting or deferral) of derivative awards that translate to 2,815 shares of common stock: 1,600, 3,101, and 2,710 RSU tranches (with portions deferred or contingent on continued service) and 541 shares of phantom stock acquired via deferral of cash board fees. Many RSUs are vested but settlement has been deferred under the company’s Non-Employee Director Equity and Deferred Compensation Plan; deferred awards become payable when the reporting person ceases to serve as a director. Some RSU tranches remain time‑vesting and are contingent on continued board service.
Lifeway Foods insider intends to sell 26,847 common shares (approximately $697,586.60 in aggregate market value) through Merrill Lynch on NASDAQ around 10/01/2025. The filing shows all 26,847 shares were acquired as compensation from the issuer on multiple dates between 07/28/2005 and 07/01/2025. The total number of outstanding shares is listed as 15,226,520, and the transaction will be executed via broker-dealer Merrill Lynch at 75 Rockefeller Plaza, New York.
Danone holds 3,454,756 shares of Lifeway Foods, representing 22.7% of the outstanding common stock based on 15,226,520 shares. This filing is Amendment No. 11 to Danone's long‑standing Schedule 13D and reports a Letter Agreement dated September 30, 2025 between Danone North America PBC and Lifeway. The Letter Agreement is designed to give Danone additional optionality to sell its stake and, among other things, requires Lifeway to maintain a shelf registration to facilitate potential sales, contemplates appointment of three independent directors within 30 days and a fourth within 45 days acceptable to Danone, contemplates an independent board chair, contains voting commitments by Danone subject to exceptions, seeks a joint effort to stay pending litigation, and includes mutual non‑disparagement and Stockholders' Agreement compliance provisions.
Lifeway Foods, Inc. disclosed changes to its agreements with Danone that limit Danone's involvement in corporate governance and certain transfer restrictions. Danone will not need to consent for the company to grant market‑term equity compensation to management (excluding JS, her immediate family and affiliates) provided the Compensation Committee—with a majority of New Independent Directors—approves the grants. Danone also waived its rights to board and committee representation and agreed to waive rights of first refusal on certain monthly sales by ES, LS and JS of up to 100,000 shares each, subject to those parties waiving claims related to shares held by Michael Smolyansky's estate. Danone's remaining Stockholders' Agreement rights (other than registration and books-and-records rights) will end once Danone and affiliates hold fewer than 761,438 shares (adjusted for recapitalizations).